Idorsia Pharmaceuticals US Inc.
A Barback at IdorTestin supports the bar team by preparing beverages, maintaining cleanliness, and ensuring excellent customer service in a fast-paced environment.
Idorsia is a Swiss biopharmaceutical company focused on discovering, developing, and delivering innovative medicines to patients with unmet medical needs. Born from the Actelion assets spun out in 2017, it maintains a diversified pipeline across neuroscience, cardiovascular, immunology, and oncology, including DARIDOREXANT for insomnia and other novel candidates like selatogrel. The company operates globally, with Idorsia US serving as its U.S. affiliate to advance development and commercialization in the United States. Grounded in science-driven innovation and patient-centric values, Idorsia aims to bring differentiated medicines to patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Idorsia Pharmaceuticals US Inc..
394% above the average for this role